A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

@article{Basu2011ARS,
  title={A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori},
  author={P. Patrick Basu and Krishna Rayapudi and Tommy Pacana and Niraj James Shah and Nithya Krishnaswamy and Molly Brigid Flynn},
  journal={The American Journal of Gastroenterology},
  year={2011},
  volume={106},
  pages={1970 - 1975}
}
OBJECTIVES:Resistance to standard Helicobacter pylori (HP) treatment regimens has led to unsatisfactory cure rates in HP-infected patients. This study was designed to evaluate a novel four-drug regimen (three antibiotics and a proton pump inhibitor (PPI)) for eradication of HP infection in treatment-naive patients.METHODS:Patients with a diagnosis of HP gastritis or peptic ulcer disease confirmed using endoscopy and stool antigen testing were eligible for inclusion in this study. All patients… Expand
Efficacy of levofloxacin, omeprazole, nitazoxanide, and doxycycline (LOAD) regimen compared with standard triple therapy to eradicate Helicobacter pylori infection: a prospective randomized study from a tertiary hospital in India
Aim: In this study, the efficacy of 14-day triple therapy was compared with that of a novel ten-day LOAD regimen to eradicate Helicobacter pylori infection in India. Background: Helicobacter pylorusExpand
Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.
TLDR
Third-line levofloxacin-doxycycline-based triple therapy had a low H. pylori eradication efficacy, though the success and tolerability of this treatment may be enhanced with probiotics. Expand
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
TLDR
Levofloxacin concomitant therapy wasn’t superior to doxycycline based quadruple therapy and further researches are required to identify the optimal first-line treatment for Helicobacter-Pylori Infection in the Syrian population. Expand
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication
TLDR
A 2-week nitazoxanide-based regimen is an effective and safe rescue therapy in Egyptian patients whose previous standard triple therapy has failed. Expand
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
TLDR
It is concluded that for eradication of H. pylori infection, the 10-day sequential therapy is more effective than the standard triple therapy and is equally tolerated. Expand
Safety and Efficacy of Nitazoxanide-Based Regimen for the Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
TLDR
Nitazoxanide-based regimen is safe and effective in the eradication of HP infection and is also successful as a salvage therapy in patients who have failed prior treatments. Expand
Nitazoxanide Use as Part of an Empiric Multi-Drug Regimen in Treating Children with Suspected Helicobacter pylori Infection
TLDR
Nitazoxanide appears to be an effective and well-tolerated option for use in combination with other agents to treat H. pylori-induced gastritis. Expand
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication].
TLDR
Moxifloxacin-containing triple therapy can be used as a second line therapy in case of hybrid therapy failure in H. pylori eradication, and it is found that compliance and adverse effects of each patient were analyzed. Expand
[The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].
TLDR
Bismuth-containing quadruple therapy is insufficient as the second line eradication treatment after a failed attempt of moxifloxacin-based sequential or reverse sequential therapy. Expand
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
TLDR
Properly designed empirical therapy, based on medication history, is an acceptable alternative to genotypic resistance-guided therapy for eradication of refractory H pylori infection after consideration of accessibility, cost, and patient preference. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials
TLDR
Ten-day triple therapy with once-daily esomeprazole plus twice-daily amoxicillin and clarithromycin achieves an eradication rate virtually identical to that of the twice- daily proton pump inhibitor–based triple therapies. Expand
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
  • S. di Caro, F. Franceschi, +6 authors A. Gasbarrini
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2009
TLDR
10 days levofloxacin-based second-line regimens were effective in curing H. pylori infection in more than 85% of patients with a lower incidence of adverse effects in lev ofloxAcin single-dosage scheme, showing that duration of therapy is the crucial factor affecting eradication rate. Expand
Treatment of Helicobacter pylori Infection
TLDR
Standard double therapy is effective in regions where clarithromycin resistance is low and Levofloxacin based triple therapy is an effective alternative to quadruple therapy in second‐line treatment. Expand
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
  • Deng-Chyang Wu, P. Hsu, +7 authors D. Graham
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2010
TLDR
Sequential or concomitant therapy with a PPI, amoxicillin, clarithromycin, and an imidazole agent are equally effective and safe for eradication of H pylori infection. Expand
Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of Doxycycline, Co-Amoxiclav, and Omeprazole in Iranian Patients
TLDR
Although none of the three eradication regimens can be recommended as a first-line eradication treatment, the new regimen is at least as effective and probably better tolerated than the two routinely applied regimens. Expand
Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication Treatments
TLDR
It seems that performing culture even after a second eradication failure may not be necessary, as it is possible to construct an overall strategy to maximize H. pylori eradication, based on the different possibilities of empirical treatment (when antibiotic susceptibilities are unknown). Expand
Sequential Therapy for Helicobacter pylori Eradication: A Critical Review
TLDR
Sequential therapy is a novel promising treatment approach that deserves consideration as a treatment strategy for H. pylori infection, but further robust assessment across a much broader range of patients is required before sequential therapy could supplant existing treatment regimens and be generally recommended in clinical practice. Expand
Treatment of Helicobacter pylori Infection
TLDR
If compliance is good and a clear treatment paradigm adhered to, almost universal eradication rates can still be achieved, if compliance is not achievable, the problem of antibiotic resistance will continue to beset any combination of drugs used for H. pylori eradication. Expand
Treatment of Helicobacter pylori infection: the past and the future.
TLDR
The ethics of continued use of standard triple therapy has recently been questioned and the use of alternative therapy has been recommended in its place, probably due to increased resistance to antibiotics. Expand
Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.
TLDR
Bismuth triple therapy is the oldest effective regimen to cure Helicobacter pylori infection, and worldwide, this drug combination is probably one of the most widely used regimens. Expand
...
1
2
3
4
5
...